Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” third quarter 2024 investor ...

Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Hello and thank you for standing by. Welcome to the Akoya ...

During the three months ended September 30, 2024, the Company sold, under the Open Market Sale Agreement with Jefferies LLC, ...

Third Quarter 2024 Financial Results Total revenue for the third quarter of 2024 was $2.0 million, an increase of 34% compared to the prior year period. Sepsis test revenue grew 34% compared to the ...

Presented full dataset from first-in-human Phase 1a clinical trial demonstrating PMN310 was generally well-tolerated with monthly dosing and that PMN310 demonstrated CSF levels indicative of potential ...

A PMDA consultation is scheduled to take place in late November as preparation for a subsequent clinical consultation after results from the CardiAMP Heart ... we caution you that forward-looking ...

Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated ...

12, 2024 /PRNewswire/ -- Edan Instruments Inc. (300206.SZ), a leading global provider of medical ... which drew widespread attention for its robust performance as a powerful solution for diverse ...

In ultrasound, EDAN highlighted the Acclarix AX9, a portable diagnostic ultrasound system featuring the cutting-edge SynSight ...

Objective To determine the association between survey-based self-reported problematic low energy availability indicators (LEA-I) and race performance and intra-event medical encounters ... of male ...

Inflammatix, a pioneering molecular diagnostics company, today announced initiation of the TriVerity™ for Improved Management of ...